Rebecca Cook
Faculty Member
Last active: 4/15/2019

Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells.

Canfield K, Li J, Wilkins OM, Morrison MM, Ung M, Wells W, Williams CR, Liby KT, Vullhorst D, Buonanno A, Hu H, Schiff R, Cook RS, Kurokawa M
Cell Cycle. 2015 14 (4): 648-55

PMID: 25590338 · PMCID: PMC4614407 · DOI:10.4161/15384101.2014.994966

MeSH Terms (13)

Animals Breast Neoplasms Cell Line, Tumor Drug Resistance, Neoplasm Female Gene Expression Regulation, Neoplastic Gene Knockdown Techniques Lapatinib Mice Quinazolines Receptor, ErbB-2 Receptor, ErbB-4 Trastuzumab

Connections (2)

This publication is referenced by other Labnodes entities:

Links